| ［1］ |
Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options［J］. J Med Microbiol, 2013, 62（Pt 1）: 10⁃24. DOI: 10.1099/jmm.0.045054⁃0.
|
| ［2］ |
Fortún J, Martín⁃Dávila P, de la Pedrosa E G, et al. Emerging trends in candidemia: a higher incidence but a similar outcome［J］. J Infect, 2012, 65（1）: 64⁃70. DOI: 10.1016/j.jinf.2012. 02.011.
|
| ［3］ |
Smeekens SP, van de Veerdonk FL, Kullberg BJ, et al. Genetic susceptibility to Candida infections［J］. EMBO Mol Med, 2013, 5（6）: 805⁃813. DOI: 10.1002/emmm.201201678.
|
| ［4］ |
Gianchecchi E, Fierabracci A. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll⁃like receptors［J］. Autoimmun Rev, 2015, 14（11）: 971⁃983. DOI: 10.1016/j.autrev.2015.07.006.
|
| ［5］ |
Plantinga TS, Johnson MD, Scott WK, et al. Toll⁃like receptor 1 polymorphisms increase susceptibility to candidemia［J］. J Infect Dis, 2012, 205（6）: 934⁃943. DOI: 10.1093/infdis/jir867.
|
| ［6］ |
Woehrle T, Du W, Goetz A, et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans［J］. Cytokine, 2008, 41（3）: 322⁃329. DOI: 10.1016/j.cyto.2007.12.006.
|
| ［7］ |
Van der Graaf CA, Netea MG, Morré SA, et al. Toll⁃like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection［J］. Eur Cytokine Netw, 2006, 17（1）: 29⁃34.
|
| ［8］ |
Rosentul DC, Delsing CE, Jaeger M, et al. Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis［J］. Front Microbiol, 2014, 5: 483. DOI: 10.3389/fmicb.2014.00483.
|
| ［9］ |
Nahum A, Dadi H, Bates A, et al. The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity［J］. Autoimmun Rev, 2012, 11（5）: 341⁃347. DOI: 10.1016/j.autrev.2011.10.007.
|
| ［10］ |
Plantinga TS, Johnson MD, Scott WK, et al. Human genetic susceptibility to Candida infections［J］. Med Mycol, 2012, 50（8）: 785⁃794. DOI: 10.3109/13693786.2012.690902.
|
| ［11］ |
Taylor PR, Tsoni SV, Willment JA, et al. Dectin⁃1 is required for beta⁃glucan recognition and control of fungal infection［J］. Nat Immunol, 2007, 8（1）: 31⁃38. DOI: 10.1038/ni1408.
|
| ［12］ |
Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin⁃1 deficiency and mucocutaneous fungal infections［J］. N Engl J Med, 2009, 361（18）: 1760⁃1767. DOI: 10.1056/NEJMoa0901053.
|
| ［13］ |
Marakalala MJ, Kerrigan AM, Brown GD. Dectin⁃1: a role in antifungal defense and consequences of genetic polymorphisms in humans［J］. Mamm Genome, 2011, 22（1⁃2）: 55⁃65. DOI: 10.1007/s00335⁃010⁃9277⁃3.
|
| ［14］ |
Rosentul DC, Plantinga TS, Oosting M, et al. Genetic variation in the dectin⁃1/CARD9 recognition pathway and susceptibility to candidemia［J］. J Infect Dis, 2011, 204（7）: 1138⁃1145. DOI: 10.1093/infdis/jir458.
|
| ［15］ |
Usluogullari B, Gumus I, Gunduz E, et al. The role of human dectin⁃1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections［J］. Mol Biol Rep, 2014, 41（10）: 6763⁃6768. DOI: 10.1007/s11033⁃014⁃3562⁃2.
|
| ［16］ |
Plantinga TS, Hamza OJ, Willment JA, et al. Genetic variation of innate immune genes in HIV⁃infected african patients with or without oropharyngeal candidiasis［J］. J Acquir Immune DeficSyndr, 2010, 55（1）: 87⁃94. DOI: 10.1097/QAI. 0b013e3181e53c64.
|
| ［17］ |
Garred P, Larsen F, Seyfarth J, et al. Mannose⁃binding lectin and its genetic variants［J］. Genes Immun, 2006, 7（2）: 85⁃94. DOI: 10.1038/sj.gene.6364283.
|
| ［18］ |
van Till JW, Modderman PW, de Boer M, et al. Mannose⁃binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis［J］. Clin Vaccine Immunol, 2008, 15（1）: 65⁃70. DOI: 10.1128/CVI.00297⁃07.
|
| ［19］ |
Nedovic B, Posteraro B, Leoncini E, et al. Mannose⁃binding lectin codon 54 gene polymorphism and vulvovaginal candidiasis: a systematic review and meta⁃analysis［J］. Biomed Res Int, 2014, 2014: 738298. DOI: 10.1155/2014/738298.
|
| ［20］ |
Donders GG, Babula O, Bellen G, et al. Mannose⁃binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis［J］. BJOG, 2008, 115（10）: 1225⁃1231. DOI: 10.1111/j.1471⁃0528.2008.01830.x.
|
| ［21］ |
Diller ML, Kudchadkar RR, Delman KA, et al. Balancing inflammation: the link between Th17 and regulatory T cells［J］. Mediators Inflamm, 2016, 2016: 6309219. DOI: 10.1155/2016/6309219.
|
| ［22］ |
Fierabracci A, Bizzarri C, Palma A, et al. A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy⁃candidiasis⁃ectodermal dystrophy syndrome （APECED）［J］. Gene, 2012, 511（1）: 113⁃117. DOI: 10.1016/j.gene.2012.09.029.
|
| ［23］ |
Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin⁃17 immunity［J］. Science, 2011, 332（6025）: 65⁃68. DOI: 10.1126/science.1200439.
|
| ［24］ |
Liu L, Okada S, Kong XF, et al. Gain⁃of⁃function human STAT1 mutations impair IL⁃17 immunity and underlie chronic mucocutaneous candidiasis［J］. J Exp Med, 2011, 208（8）: 1635⁃1648. DOI: 10.1084/jem.20110958.
|
| ［25］ |
Johnson MD, Plantinga TS, van de Vosse E, et al. Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study［J］. Clin Infect Dis, 2012, 54（4）: 502⁃510. DOI: 10.1093/cid/cir827.
|
| ［26］ |
Sun RT, Tian WJ, Xing XW, et al. Association of cytokine gene polymorphisms with susceptibility to invasive candidiasis［J］. Genet Mol Res, 2015, 14（2）: 6859⁃6864. DOI: 10.4238/2015.June.18.29.
|
| ［27］ |
Glocker EO, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections［J］. N Engl J Med, 2009, 361（18）: 1727⁃1735. DOI: 10.1056/NEJMoa0810719.
|
| ［28］ |
Jaeger M, Carvalho A, Cunha C, et al. Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC［J］. Eur J Clin Microbiol Infect Dis, 2016, 35（5）: 797⁃801. DOI: 10.1007/s10096⁃016⁃2600⁃5.
|
